Harmony Biosciences Holdings Inc (HRMY) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Harmony Biosciences Holdings inc   (NASDAQ: HRMY)
 

Harmony Biosciences Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Harmony Biosciences Holdings Inc inventory turnover ratio, the Harmony Biosciences Holdings Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 39.56 in the second quarter 2026, a new company high. Average inventory processing period, for the Harmony Biosciences Holdings Inc in Jun 30 2026 quarter, has decreased to 9 days, compare to 10 days, in the Mar 31 2026 quarter.

Within Healthcare sector 2 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 110 in the first quarter 2026, to 124.

HRMY Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Harmony Biosciences Holdings Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HRMY Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 4.26 % -17.28 % -25.58 % -0.48 % 8.1 %
Y / Y Cost of Sales Growth 66.31 % 41.94 % 27.27 % 40.48 % 18.75 %
Inventory Turnover Ratio (TTM) 39.56 35.73 32.03 27.56 24.97
HRMY's Total Ranking # 124 # 110 # 91 # 67 # 140
Average inventory processing period 9 10 11 13 15
Seq. Inventory Growth 20.43 % -1.42 % -22.16 % 12.82 % -4.45 %
Seq. Cost of Sales Growth 43.63 % -37.14 % 18.64 % 55.26 % 22.58 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 0
Healthcare Sector # 3
Overall Market # 124

Inventory Turnover Ratio Statistics
High Average Low
39.56 20.94 4.25
(Jun 30 2026)   (Dec 31 2020)



HRMY Company Profile >> Back to HRMY Efficiency Comparisons >> Compare HRMY Inventory Turnover Ratio to its Competitors

Financial Statements
Harmony Biosciences Holdings Inc 's Inventories $ 6 Millions Visit HRMY's Balance sheet
Harmony Biosciences Holdings Inc 's Cost of Revenues TTM $ 236 Millions Visit HRMY's Income Statement
What are HRMY's Sales? Visit HRMY's Sales by Segment

Other Inventory Turnover Ratios
Harmony Biosciences Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
HRMY's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for HRMY's Competitors
Inventory Turnover Ratio for HRMY's Suppliers
Inventory Turnover Ratio for HRMY's Customers

You may also want to know
HRMY's Sales Growth Rates HRMY's Pe Price to earnings ratio HRMY's Receivables Turnover Ratio HRMY's Stock Quote
HRMY's Net Income Growth Rates HRMY's Ps Price to Sales ratio HRMY's Sales per Employee HRMY's Asset Turnover Ratio
HRMY's Net Margin HRMY's Pb Price to Book ratio HRMY's Financial Strength Ratios HRMY's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Harmony Biosciences Holdings inc   39.56 $ 236.198  Millions$ 6  Millions
Qhslab Inc   39.48 $ 0.975  Millions$ 0  Millions
Quest Diagnostics Inc  37.13 $ 7,732.000  Millions$ 208  Millions
Vaso Corporation  33.32 $ 28.238  Millions$ 1  Millions
Omada Health Inc   24.96 $ 97.232  Millions$ 4  Millions
Aspira Women s Health inc   22.57 $ 5.988  Millions$ 0  Millions
Prophase Labs Inc   22.13 $ 2.633  Millions$ 0  Millions
Lucid Diagnostics Inc   21.74 $ 9.740  Millions$ 0  Millions
Sbc Medical Group Holdings Incorporated  19.68 $ 48.095  Millions$ 2  Millions
Adapthealth Corp   18.95 $ 2,676.899  Millions$ 141  Millions
Precipio inc   18.05 $ 15.200  Millions$ 1  Millions
Rockwell Medical inc   17.36 $ 57.537  Millions$ 3  Millions
Neuronetics Inc   16.61 $ 78.345  Millions$ 5  Millions
Rosecliff Acquisition Corp I  14.94 $ 9.597  Millions$ 1  Millions
Catheter Precision Inc   14.83 $ 1.001  Millions$ 0  Millions
Agape Atp Corporation  14.52 $ 0.413  Millions$ 0  Millions
Edap Tms Sa  12.79 $ 62.351  Millions$ 5  Millions
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Irhythm Holdings Inc   10.79 $ 235.967  Millions$ 22  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Lantheus Holdings Inc   10.09 $ 619.325  Millions$ 61  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions

Date modified: 2026-08-30T20:51:22+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.